Blood glucose monitoring through finger-stick testing or continuous glucose monitors should occur at baseline, during each dose adjustment, and at least every 3 months once stable
Factors such as hydration status, personal hygiene, and pre-existing conditions also play significant roles in UTI development
2024 Wegovy Study Finds NAION Risk for Weight Loss and Diabetes Patients Another JAMA Ophthalmology study from 2024 found a higher risk of NAION in people prescribed semaglutide, regardless of whether they had Type 2 diabetes or were overweight
Then, we discuss an article that explores a novel class of immunotherapy treatments to combat cancer
Combining the two supplements can help enhance strength, endurance, fat loss and lean muscle growth while reducing fatigue
J Bone Miner Res 35(8):14151423 Herrou J, Mabilleau G, Lecerf JM, Thomas T, Biver E, Paccou J (2024) Narrative review of effects of Glucagon-Like Peptide-1 Receptor Agonists on bone health in people living with obesity